GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bonus BioGroup Ltd (XTAE:BONS) » Definitions » Deferred Policy Acquisition Costs

Bonus BioGroup (XTAE:BONS) Deferred Policy Acquisition Costs


View and export this data going back to 1993. Start your Free Trial

What is Bonus BioGroup Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Bonus BioGroup Business Description

Industry
Traded in Other Exchanges
Address
Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.